Gerald Friedman Diabetes Institute — New York, New York

Gerald Friedman Diabetes Institute is a clinical research site located in New York, New York, United States 10022.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Gerald Friedman Diabetes Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypoparathyroidism.

Sponsors: Takeda.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Gerald Friedman Diabetes Institute?

Gerald Friedman Diabetes Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Gerald Friedman Diabetes Institute conducted?

Gerald Friedman Diabetes Institute has 1 clinical trials on record, with 1 currently active. Their work covers Hypoparathyroidism.

Is Gerald Friedman Diabetes Institute accredited by Crixeo Health?

Gerald Friedman Diabetes Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Gerald Friedman Diabetes Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.